Zou Yizhou, Stastny Peter, Süsal Caner, Döhler Bernd, Opelz Gerhard
Transplantation Immunology Division, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390-8886, USA.
N Engl J Med. 2007 Sep 27;357(13):1293-300. doi: 10.1056/NEJMoa067160.
Good HLA-A, HLA-B, and HLA-DR matches do not guarantee rejection-free renal transplantation. Some kidney transplants fail despite such matches, suggesting that other antigens might be targets for rejection. Major-histocompatibility-complex (MHC) class I-related chain A (MICA) antigens are polymorphic and can elicit antibody production. We sought to determine whether an immune response to MICA antigens might play a role in the failure of kidney allografts.
Pretransplantation serum samples from 1910 recipients of kidney transplants from deceased donors were tested for anti-MICA antibodies with an assay in which single MICA antigens were attached to polystyrene microspheres.
Antibodies against MICA alleles were detected in 217 of the 1910 patients (11.4%). The presence of MICA antibodies was associated with renal-allograft rejection. The mean (+/-SE) 1-year graft-survival rate was 88.3+/-2.2% among recipients with anti-MICA antibodies as compared with 93.0+/-0.6% among recipients without anti-MICA antibodies (P=0.01). Among recipients of first kidney transplants, the survival rate was even lower among MICA antibody-positive patients (87.8+/-2.4%) than among MICA antibody-negative recipients (93.5+/-0.6%, P=0.005). In addition, the association of MICA sensitization with reduced graft survival was more evident in kidney-transplant recipients with good HLA matching: among 326 recipients who received well-matched kidneys (0 or 1 HLA-A plus HLA-B plus HLA-DR mismatch), sensitization against MICA was associated with poorer allograft survival (83.2+/-5.8% among those with anti-MICA antibodies vs. 95.1+/-1.3% among those without such antibodies, P=0.002).
Presensitization of kidney-transplant recipients against MICA antigens is associated with an increased frequency of graft loss and might contribute to allograft loss among recipients who are well matched for HLA.
良好的人类白细胞抗原A(HLA-A)、HLA-B和HLA-DR配型并不能保证肾移植无排斥反应。尽管有这样的配型,一些肾移植仍会失败,这表明其他抗原可能是排斥反应的靶点。主要组织相容性复合体(MHC)I类相关链A(MICA)抗原具有多态性,可引发抗体产生。我们试图确定对MICA抗原的免疫反应是否可能在同种异体肾移植失败中起作用。
采用将单个MICA抗原附着于聚苯乙烯微球的检测方法,对1910例接受已故供者肾移植受者移植前的血清样本进行抗MICA抗体检测。
1910例患者中有217例(11.4%)检测到针对MICA等位基因的抗体。MICA抗体的存在与肾移植排斥反应相关。抗MICA抗体受者的1年移植肾存活率平均(±标准误)为88.3±2.2%,而无抗MICA抗体受者为93.0±0.6%(P = 0.01)。在首次肾移植受者中,MICA抗体阳性患者的存活率(87.8±2.4%)甚至低于MICA抗体阴性受者(93.5±0.6%,P = 0.005)。此外,MICA致敏与移植肾存活率降低之间的关联在HLA配型良好的肾移植受者中更为明显:在326例接受良好配型肾脏(0或1个HLA-A加HLA-B加HLA-DR错配)的受者中,对MICA致敏与移植肾存活率较低相关(抗MICA抗体者为83.2±5.8%,无此类抗体者为95.1±1.3%,P = 0.002)。
肾移植受者对MICA抗原的预致敏与移植肾丢失频率增加相关,可能导致HLA配型良好的受者移植肾丢失。